Search

The PICI@MSK fellowship will provide Dr. Delconte with two years of financial support for her research on natural killer cells in cancer.

… Wednesday, March 17, 2021 Rebecca Delconte is a postdoctoral fellow working in the lab of immunologist Joseph Sun in the Sloan Kettering Institute. She is the recipient of the 2021-2022 Parker Institute for Cancer Immunotherapy at MSK  Postdoctoral Fellowship, which will provide two years of financial

The engineered immune cells secrete powerful drugs as a layer of defense.

… Monday, August 13, 2018 Summary A technological advance may make a cell-based immunotherapy more effective against hard-to-treat cancers. Scientists at Memorial Sloan Kettering announced today that they have built a new model of genetically engineered immune cells, ones with powerful “armor” that may

MSK’s Supportive Care Service aims to improve quality of life for all people with cancer.

… Thursday, February 15, 2018 Summary People with cancer and their families can benefit from supportive care services regardless of their type or stage of disease. The doctors, nurses, and other staff at Memorial Sloan Kettering are focused on all aspects of cancer care. This means that in addition to

Degrees were presented and awards were given at the 39th annual ceremony, held on May 30.

… Friday, June 1, 2018 GSK group photo Leadership from MSK (seated) with PhD recipients from GSK and Weill Cornell at the May 30 ceremony Neuroscientist Cori Bargmann Neuroscientist Cori Bargmann, recipient of the Memorial Sloan Kettering Medal for Outstanding Contributions to Biomedical Science MSK President

Even the most common cancers have aspects that are not fully grasped by the public.

… Saturday, December 15, 2018 Summary The five most common cancers in the United States are skin cancer , lung cancer , breast cancer , prostate cancer , and colorectal cancer . MSK specialists in each of these diseases say there are aspects of them that many people overlook or do not fully appreciate.

MSK researchers have identified two signaling pathways that work together to spur the spread of lung cancer. Taking away one of those signals could help slow or stop metastasis, findings in animal models suggest.

… Friday, September 6, 2024 When it comes to cancer metastasis, it takes two to tango. That was one of the key findings of a new study led by researchers at Memorial Sloan Kettering Cancer Center (MSK): The TGF-beta and RAS signaling pathways work together to spur the spread of cancer in lung adenocarcinoma

Several Memorial Sloan Kettering Cancer Center (MSK) physician-scientists have been recognized by the American Society of Clinical Oncology (ASCO).

… Thursday, May 30, 2024 Several Memorial Sloan Kettering Cancer Center (MSK) physician-scientists have been recognized by the American Society of Clinical Oncology (ASCO). Every year, ASCO recognizes individuals who have made significant contributions to ASCO, the practice of clinical oncology, people

Chemotherapy is a common treatment for acute myeloid leukemia, but patients often stop responding. Until now, not much was known about why.

… Friday, December 2, 2016 Summary Acute myeloid leukemia is usually treated with chemotherapy , but patients often stop responding to these drugs and develop resistance to them. Now MSK investigators are learning why that is the case. Highlights Acute myeloid leukemia is the most common acute leukemia

Even as a child, physician-scientist Veronica Rotemberg always knew that her future self would be wearing a lab coat. Learn more about her journey and research.

… Monday, April 29, 2024 Veronica Rotemberg, MD, PhD , Director of Dermatology Informatics Program at Memorial Sloan Kettering Cancer Center (MSK), and leader of her own lab at Memorial Hospital, is passionate about her patients, technology, and the future. She has been a member of the MSK faculty for

For many patients, time is of the essence. At MSK, patients have access to potentially lifesaving therapies long before they are available at community hospitals. Learn how MSK’s Cancer Health Equity Research Program (CHERP) partners with a network of public hospitals in New York City to recruit underserved patients for clinical trials at MSK and give them access to world-class care.

… Tuesday, December 6, 2022 Berta Pesantez knew the outlook wasn’t good. She had stage 4 cancer of the bile duct , and the chemotherapy she was receiving at her local hospital wasn’t working. Out of options, the doctor transferred Berta to the New York’s Queens Cancer Center (QCC), in Jamaica. Berta’s